Literature DB >> 16139923

The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study.

Ka Yu Tse1, Lai Fong Ho, Terence Lao.   

Abstract

BACKGROUND/AIMS: To examine the impact of maternal HBsAg carrier status on pregnancy outcomes.
METHODS: Two hundred and fifty-three carriers of hepatitis B surface antigen (HBsAg) with singleton pregnancy, were retrospectively compared with 253 controls matched for age and parity and year of delivery.
RESULTS: On univariable analysis, HBsAg carriers had higher incidences of threatened preterm labour at <37 weeks (11.9% vs. 6.3%, P=0.030), preterm birth at <34 weeks (4.7% vs. 1.2%, P=0.033), gestational diabetes mellitus (19.0% vs. 11.1%, P=0.012) and antepartum haemorrhage (11.5% vs. 5.5%, P=0.026). Their infants had lower Apgar scores at the 1st (8.47+/-1.67 vs. 8.87+/-1.07, P=0.001) and 5th minute (9.56+/-1.29 vs. 9.80+/-0.54, P=0.007), and increased incidence of intraventricular haemorrhage (4.7% vs. 0.8%, P=0.007). On multivariable analysis, the association between HBsAg carrier state with antepartum haemorrhage, gestational diabetes mellitus and threatened preterm labour were confirmed.
CONCLUSIONS: HBsAg carriers have increased risk of gestational diabetes mellitus, antepartum haemorrhage, and threatened preterm labour. This may be related to the chronic inflammatory state in these subjects. The role of chronic HBV infection in pregnancy complications has to be further elucidated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139923     DOI: 10.1016/j.jhep.2005.05.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

1.  Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission.

Authors:  Manisha Dwivedi; Sri Prakash Misra; Vatsala Misra; Arvind Pandey; Sanjay Pant; Rita Singh; Manju Verma
Journal:  Indian J Gastroenterol       Date:  2011-04-16

Review 2.  Management of chronic hepatitis B in patients from special populations.

Authors:  Ching-Lung Lai; Man-Fung Yuen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 3.  Chronic hepatitis B virus infection and pregnancy.

Authors:  Manoj Kumar; Tarandeep Singh; Swati Sinha
Journal:  J Clin Exp Hepatol       Date:  2012-09-20

4.  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.

Authors:  Wei Yi; Min Liu; Hao-Dong Cai
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

5.  Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis.

Authors:  Kaiqi Wu; Hong Wang; Shuai Li; Hong Zhang; Bo Zhu
Journal:  Arch Gynecol Obstet       Date:  2020-07-23       Impact factor: 2.344

Review 6.  Hepatitis B and C in pregnancy: a review and recommendations for care.

Authors:  J C Dunkelberg; E M F Berkley; K W Thiel; K K Leslie
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

7.  Impact of hepatitis B virus carrier serostatus on neonatal outcomes after IVF-ET.

Authors:  Shengli Lin; Rong Li; Xiaoying Zheng; Lina Wang; Xiulian Ren; Lixue Chen; Qinli Liu; Ping Liu; Jie Qiao
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 8.  Management of chronic hepatitis B in pregnancy.

Authors:  Guo-Rong Han; Chuan-Lu Xu; Wei Zhao; Yong-Feng Yang
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

9.  Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV.

Authors:  V Mave; D Kadam; A Kinikar; N Gupte; D Bhattacharya; R Bharadwaj; K McIntire; V Kulkarni; U Balasubramanian; N Suryavanshi; C Thio; P Deshpande; J Sastry; R Bollinger; A Gupta; R Bhosale
Journal:  HIV Med       Date:  2014-01-14       Impact factor: 3.180

Review 10.  Current recommendations of managing HBV infection in preconception or pregnancy.

Authors:  James S Park; Calvin Pan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.